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Abstract
Objective: To present a series of localized fibrous tumours of the pleura (LFTP), to define the clinical and histopathological diagnostic
criteria of this tumour, and to determine the optimal treatment and follow-up. Methods: Review of the charts of the patients with the
diagnosis of LFTP (formerly called benign fibrous mesothelioma), as well as of all the histological sections, including immunohistochem-
ical stains. Review of the literature with special emphasis on the clinical and histological criteria of malignancy. Results: During the last 30
years, we found 15 patients with a complete clinical chart and histological material, particularly paraffin blocks of the tumour. The mean
age was 57 years (range 27–79). Eight patients were asymptomatic, and the remaining seven presented with non-specific symptoms. All but
one had complete resection of the tumour, including partial lung resection in two and partial chest wall resection in three. The diagnosis was
confirmed by histological review in 15 cases. Immunohistochemical stainings showed positivity for vimentin in all cases, for CD 34 in 80%,
but were consistently negative for cytokeratins. Nine tumours were histologically classified as malignant. Among them, five recurred, two
of which were responsible for death. One benign tumour recurred after 1 year, and was treated successfully by repeat resection and
radiotherapy. Overall, 13 patients (86%) were alive with no evidence of disease between 10 months and 27 years after the first resection.
Conclusions: LFTP is a rare tumour which has a benign clinical course in over 80% of the cases, and is asymptomatic in half the patients.
The diagnosis is difficult to establish before operation. Treatment consists of complete resection including adjacent structures if necessary.
The clinical behaviour of LFTP cannot be predicted on the basis of histological aspects only. If histologically malignant tumours are more
prone to recurrence and poor outcome, broad-based and locally invasive tumours bear a higher risk of recurrence. Long term follow-up is
therefore mandatory in all cases in order to perform early re-resection when recurrence occurs. Ó 1998 Elsevier Science B.V. All rights
reserved
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1. Introduction
Primary tumours of the pleura are of two types: diffuse
and solitary. The diffuse type, malignant mesothelioma, is
well known for its dismal prognosis and its close relation-
ship with exposure to asbestos. There is more confusion
about the solitary type. It has a variety of names, the most
common being localized fibrous tumour of the pleura
(LFTP) or benign fibrous mesothelioma. LFTP is rare and
often asymptomatic, which explains why the diagnosis is
often delayed, and usually not made before thoracotomy.
There is still controversy about the origin of this tumour
and about its malignant potential. The pathologist has to
make the distinction between benign and malignant LFTP,
but even if the tumour is histologically correctly classified,
the clinical outcome cannot definitely be predicted. A large
clinico-pathological study was reported by England in 1989,
who emphasised histologic features of these tumours [1]. In
that series of 223 patients, England and his co-workers ana-
lyzed the histological aspects of LFTP and the clinical out-
come. They found three histopathological criteria
associated with malignancy: marked cellularity with crowd-
ing and overlapping of nuclei, increased mitotic activity
(.4 mitotic figures/10 high power fields), and nuclear pleo-
morphism.
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In order to clarify the understanding of LFTP, we
reviewed our series and present 15 new cases together
with a review of the literature.
2. Material and methods
The files of the last 30 years of the Institute of Pathology
and the University Hospital (Centre Hospitalier Universi-
taire Vaudois) in Lausanne were computed to find all the
patients with the diagnosis of LFTP or benign fibrous
mesothelioma. The patients were included if the clinical
chart as well as the pathological specimen were available.
Special attention was given to the demographic data such as
age and sex, and to the presenting symptoms, the radiolo-
gical aspects, and the results of the pre-operative investiga-
tions. The operative reports were reviewed, and it was noted
whether the mass was unique or not, pedicled or not, well
delineated or not. The size of the tumour and its origin
(visceral vs. parietal pleura) and the completeness of resec-
tion were also assessed. Duration of follow-up and any
intercurrent event related or not to the tumour were
recorded.
Histology of all the resected specimens was reviewed.
Hematoxylin and eosin stained histological sections from
formaldehyde-fixed, paraffin-embedded tissues were avail-
able for all the patients. Immunohistochemical stains
against cytokeratins (low and high molecular weights),
vimentin, muscle cell markers (desmin, muscle actins
HHF-35 and alpha smooth muscle actin) and CD34 were
also performed. For those lesions confirmed to be LFTP,
criteria of malignancy as defined by England [1] were eval-
uated. These included marked cellularity with crowding and
overlapping of nuclei, increased mitotic activity (.4 mitotic
figures/10 high power fields), and nuclear pleomorphism.
Tumours were considered to be malignant if one or more
of these parameters were present, even focally.
3. Results
A total of 18 patients with the diagnosis of benign
mesothelioma of the pleura or fibrous tumour of the pleura
were found during the last 30 years. Three were excluded
from further analysis because the paraffin blocks and/or
histologic sections of the tumour were missing. Therefore,
15 patients, six men and nine women with a mean age of 57
years (range 27–79) were reviewed. The clinical features
and the work-up are summarized in Table 1. In five cases,
the tumour was diagnosed between 1 and 7 years before
resection was considered. No patient gave a history of expo-
sure to asbestos.
The chest X-ray showed a well delineated mass in 14
cases (Fig. 1). One patient had two masses. Eight patients
had computerized tomography. It showed a homogeneous
and well defined mass in five, and a large, polycyclic and
heterogeneous mass in three. Bronchoscopy was normal in
six cases, and showed extrinsic compression of the bron-
chial tree in four. Transparietal biopsy was performed five
times. It was concluded to be a mesenchymal tumour of
dubious nature in one, a benign fusocellular tumour in
one, LFTP in one, and a tumour of presumed neural origin
in one. The material was inadequate in the last case.
All patients underwent thoracotomy (Table 2). In one
case, a diagnostic thoracoscopy was performed first.
Seven had a mass which moved freely, and was attached
by a highly vascular pedicle to the pleura. Complete
removal of the lesion with at least a 10 mm margin in all
directions was performed in all cases. Three patients had
concomitant resection of one, two or four ribs, respectively,
because of dense adhesions between the mass and the chest
wall. One patient required middle lobectomy, and one upper
right lobectomy. No patient underwent extended pleurect-
omy. The post-operative course was uneventful in all but
two patients. One had a persisting apical pneumothorax for
several days that resolved spontaneously. Another had a
Table 1
Clinical and radiological features of the patients
Age (years) Clinical features Radiological features CT FNA Bronchoscopy
AMV 27 No symptom 2 WC masses No No No
SD 62 C, P WC hilar mass No No Yes
RC 63 C, H Peripheral WC mass Yes Yes No
SP 74 D, HG Large WC mass Yes No Yes
CN 61 No symptom WC mass No No Yes
DV 35 No symptom WC mass No No Yes
EH 36 No symptom WC posterior mass Yes Yes No
WB 44 No symptom WC parahilar mass Yes/No No Yes
CW 60 D, C, P, DC WC basal mass Yes No No
LP 65 No symptom Large WC mass No Yes Yes
OC 58 C, P WC apical mass No No Yes
GT 63 C, P WC mass No No Yes
EP 69 No symptom Large mass Yes Yes No
RP 63 No symptom WC mass Yes Yes Yes
GD 69 D Very large mass Yes No Yes
D, dyspnea; C, cough; H, hemoptysia; P, pain; DC, digital clubbing; HG, hyperglycemia; WC, well circumscribed.
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severe post-operative haemorrhage, and required two re-
thoracotomies within 12 h of resection. There was no peri-
operative death.
Two patients died from respiratory failure due to massive
local recurrence 5 and 10 months after resection. Another
patient had recurrence after 4 years and was reoperated. He
was lost from follow-up 2 years later with no evidence of
disease. For the remaining patients, duration of follow-up is
between 10 months and 27 years. Six patients have been lost
after 1–15 years (mean 5.6) but were alive with no recur-
rence at that time. The others, including one woman who
had recurrence after 6 years and complete re-resection, and
another patient with recurrences and re-resection 18 and 25
years after primary resection, are doing well between 10
months and 27 years (mean 9 years) after the first operation.
A benign LFTP (formerly called benign fibrous mesothe-
lioma) was diagnosed at the initial histologic examination in
14 cases. In one case, the diagnosis was that of a malignant
fibrous tumour of the pleura. Review of the histologic sec-
tions and immunohistochemical studies showed micro-
scopic features consistent with the diagnosis of LFTP in
all cases (Table 2) [1,2]. The cellularity varied greatly
from tumour to tumour, but also from field to field within
a single tumour. Nine tumours were classified as malignant
in view of England’s criteria (initially only one), and the
remaining six were confirmed to be benign (Figs. 2 and 3).
No correlation was found between microscopic malignancy
and the size of the tumour. Foci of necrosis (three cases)
were only seen in malignant tumours. Immunohistochemi-
cal studies revealed vimentin expression in all these tumours
and CD34 in 11 (80%). lmmunoreactivity for cytokeratins
was consistently negative. Seven tumours (47%), six of
which were histologically malignant, expressed at least
one muscle cell marker. Overall, eight tumours were
wrongly interpreted as benign at initial histology, but Eng-
land’s criteria were not used at that time.
4. Discussion
The first description of a primary tumour of the pleura is
attributed to Lieutaud in 1767 [3]. In 1870, Wagner was the
first to report the detailed histologic description of a tumour
he thought was derived from the endothelium of the pleural
lymphatics. Klemperer and Rabin in 1931 [4] divided pri-
mary tumours of the pleura into two categories: diffuse and
localized. The diffuse form was assumed to derive from the
mesothelial cells, whereas the localized tumours were
derived from the submesothelial layer. The diffuse form,
malignant mesothelioma, represents 75–90% of the cases
[5,6]. It is clearly related to the exposure to asbestos. The
localized form, LFTP, represents about 17% of all benign
intrathoracic tumours [7].
LFTP arises at varying ages. As our series shows, it is
more frequent during the fifth and sixth decades. No case
has been reported during childhood, and there is no sex
predominance. The cause is unknown, and no relationship
with the exposure to asbestos has been found. The lesion is
asymptomatic in over 50% of the cases (53% in this series)
[3,5,6,8–10]. Most of these tumours are found incidentally
Fig. 1. BW, male, 44 years. Chest X-ray (pa and lateral views): well
localized and well delineated oval mass.
Fig. 2. Localized benign fibrous tumour of the pleura: low cellularity with
loosely arranged spindle cells scattered haphazardly among strands of
collagen fibers (HE, · 165).
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on routine chest radiographs. Symptoms tend to be more
common in larger lesions. As for our patients, symptoms
include mainly non-specific thoracic symptoms such as
chest pain, dyspnea, cough, and more rarely hemoptysis.
The feeling of a moving mass within the chest has been
reported. Extrathoracic symptoms may include weakness,
fever, weight loss, nocturnal sweating, chills. Digital club-
bing (one case in this series) or hypertrophic osteoarthro-
pathy has been reported in up to 20% of the patients
[8,9,11,12]. Hypertrophic osteoarthropathy is more com-
monly associated with LFTP than with bronchial carci-
noma, although it was present in none of our patients.
This is attributed to the fact that tumour cells may produce
hyaluronic acid, which has an osteolytic effect [12]. Recur-
rent episodes of hypoglycemia (one case in this series) are
observed in 2–4% of the cases [3,8,13]. Hypoglycemia
could be related to the production by the tumour of insu-
lin-like growth factor II (IGF-II), which causes an increased
glucose utilization and an impaired growth hormone coun-
ter-regulatory response to hypoglycemia [14]. In our
patients, all the symptoms regressed completely after surgi-
cal resection, as is normally reported in the literature.
As in most patients in this series, LFTP appears as a well
delineated round, ovoid, or polycyclic mass on the standard
chest X-ray (Fig. 1). If the lesion is pedunculated, the posi-
tion of the mass can change, which should be suggestive of
the diagnosis. Serous pleural effusion affects fewer than
10% of the patients, and was present in none of our patients
[5,8,15–18]. On the other hand, an exsudative effusion is
present in 80% of the patients with diffuse malignant
mesothelioma [5]. Computerized tomography is an impor-
tant step in the pre-operative work-up [5,10,18–20]. CT
shows a tissular mass which is homogeneous in most
cases (seven out of eight who had CT in our series), espe-
cially when the size of the lesion is small. Larger tumours
may show a heterogeneous aspect. The contour of the mass
is well delineated. The tumour usually does not invade adja-
cent structures. A few cases with calcifications have been
reported. The angles between the tumour and the chest wall
can be acute and suggest a parenchymal mass. When the
tumour is close to the mediastinum or the diaphragm, its
relationship with the surrounding structures is sometimes
difficult to assess. Magnetic resonance imaging can show
the fibrous character of the mass [20]. Echography can help
to precisely locate the tumour in relation to the diaphragm.
Unfortunately, no radiologic modality is diagnostic for
LFTP, or can differentiate between benign or malignant
lesions. We do not recommend transthoracic needle biopsy
because of its poor diagnostic yield [5,10,20,21]. Five of our
patients had such a biopsy, but LFTP was diagnosed in only
one. Bronchoscopy is necessary to rule out endobronchial
disease [10,17]. Extrinsic bronchial compression can some-
times be seen, as in four of our cases.
Macroscopically, LFTP is a unique mass in most cases.
The size is variable, and tumours as great as 36 cm in
diameter or weighing up to 4.5 kg have been reported
[22,23]. Multiple tumours, such as in one of our patients,
are extremely rare [1,8] (Fig. 4). Most tumours are round or
ovoid. In large tumours, the shape of the mass is adapted to
the anatomy of the hemithorax. The mass is usually well
circumscribed and sharply delineated, as in 12 (80%) of our
patients. It is often encapsulated within a thin membrane,
which consists of collagen covered by normal mesothelial
cells. The tumour is attached to the pleura by a highly vas-
cular pedicle in 38–42% of the cases (46% in our cases)
[1,9]. The base of the tumour is on the visceral pleura in
Table 2
Therapy, tumour features and outcome
Side Origin Form Surgery Histology England Immuno FU Outcome
H A M C V D
AMV R P S Re B LFTP - - - - + - 288 Alive
SD L V S Re M LFTP + - - - + + 180 Alive
RC L V S Re M LFTP + - - - + + 48 Alive
SP R M P Re M LFTP + + - - + + 5 Died
CN L V P Re B LFTP - - - - + + 36 Alive
DV L V P Re B LFTP - - - - + + 12 Alive
EH L V P Re B LFTP - - - - + + 18 Alive
WB R V P Re B LFTP - - - - + + 36 Alive
CW R V S L+W M LFTP + - - - + + 324 Alive
LP R V P Re B LFTP - - - - + + 144 Alive
OC R V S L+W M LFTP - + - - + - 10 Died
GT L P S Re+PP M LFTP + + - - + - 24 Alive
EP R P S Re M LFTP + - + - + + 30 Alive
RP L V P Re M LFTP + + + - + + 8 Alive
GD L P S Re+W M LFTP + + - - + + 36 Alive
R, right; L, left; P, parietal pleura; M, mediastinal pleura; V, visceral pleura;
P, pedicled tumour; S, tumour with large base; Re, resection with 10 mm or more safety margin; Re + W, resection together with part of the chest wall; L,
lobectomy; L + W, lobectomy and chest wall resection; Re + PP, resection and total parietal pleurectomy,
B LFTP, benign LFTP; M LFTP, malignant LFTP; H, hypercellularity; A, atypia; M, >4 mitoses/high power field; C, cytokeratine; V, vimentine; D, CD-34.
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about three quarters of the patients (66% in this series) [6,7].
Other tumours have a broad base, and some lesions (7%)
grow inward the lung parenchyma [24].
Histologically, the so-called patternless pattern predomi-
nates: fibroblast-like spindle cells and connective tissue in
varying proportions are arranged at random. In about 25%
of the cases, this pattern coexists with a prominent network
of capillaries and large vessels, and the general aspect is
suggestive of a hemangiopericytoma. The size and shape
of the cells and nuclei are usually uniform, and few mitoses
can be observed (,4 mitoses/10 high power fields) [1,3].
Small areas of lung tissue, bronchus or even mesothelium
can be found within the tumour. England, in an extensive
anatomopathological analysis of 223 cases, found 36% of
the patients to have a malignant tumour [1]. In another
series, 15% of the tumours were microscopically malignant
[9]. Interestingly, 60% of our LFTP were histologically
malignant according to England’s criteria. We have no
explanation for this unusually high rate.
Controversy still exists about the origin of LFTP, which
explains the many terms that have been used. Contrarily to
Klemperer and Rabin, Stout and Murray in 1942 concluded
that the mesothelial cell was the origin of LFTP [25]. More
recently, other authors again considered fibroblasts from the
submesothelial layer to be the origin of the tumour [1,26–
28]. They based their conclusions on the ultrastructural
aspects and the immunohistochemical characteristics of
the tumour cells. As in our series, immunohistochemical
studies are positive for vimentin, a marker of mesenchymal
differentiation, often positive for CD34, and sometimes
positive for muscle cell markers, but negative for cytoker-
atins and KL1 [1,8,27,29–33]. The positivity for vimentine
and negativity for KL1 support the fibroblastic origin of
these tumours [32,33]. The ultrastructural aspects of the
Fig. 3. Localized malignant fibrous tumour of the pleura: (a) high cellu-
larity with interlacing fascicles of plump cells and scanty collagen fibers
(HE, · 165); (b) high power view showing nuclear pleomorphism and
mitotic activity (HE, · 330).
Fig. 4. AMV, 27 years, female: chest X-ray (front and lateral views)
showing two well circumscribed masses in the right upper thorax, both
of which proved to be benign LFTPs.
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cells (absence of microvilli, basal lamina, desmosomes,
tonofilaments, but developed rough endoplasmic reticulum)
also support a non-mesothelial, but fibroblastic origin [28].
In our series, the differences between the initial histologic
diagnosis and the diagnosis after histological review using
England’s criteria reflects the difficulties encountered by the
pathologist who faces these tumours. Even if LFTP was
correctly recognised in 100% of our cases, 53% of those
initially interpreted as benign, were in fact malignant.
The differential diagnosis of an intrathoracic mass is
wide, and as a rule, such lesions should be considered as
malignant until proved otherwise. The diagnosis of LFTP is
very difficult pre-operatively, and even if it can be made, the
difference between benign and malignant lesions is difficult
as the histological aspects can vary between different areas
in the same tumour. Although our experience is limited to
one case, we believe that thoracoscopy could be used at
least for diagnosis, or even for resection of small peduncu-
lated tumours in some cases. In the remaining patients,
thoracotomy is indicated for diagnosis and treatment. The
latter includes complete surgical resection of the tumour,
with a margin of normal tissue that depends on the general
aspects of the mass, but should include a safety margin of at
least 10 mm. Pleurectomy is not necessary. For peduncu-
lated tumours, resection at the base of the pedicle with a
small patch of lung parenchyma is sufficient. Care must be
taken, however, because the pedicle is usually highly vas-
cular. Formal lung resection, i.e. lobectomy or segmentect-
omy along with the tumour is seldom required, even for
tumours broadly based on the visceral pleura or inverted
into the parenchyma. A lobectomy had to be performed in
two of our cases. For tumours originating from the parietal
pleura, extrapleural resection, and sometimes partial exci-
sion of the chest wall with reconstruction is necessary to
achieve a sufficient safety margin, as in three of our patients.
In most cases, however, separation of the mass from adja-
cent structures is easy to achieve. As shown by our series,
the post-operative course is usually uncomplicated, and the
pre-operative symptoms disappear after resection. In the
asymptomatic patients, it may be argued that resection is
not necessary because some of these tumours are benign.
Thoracotomy, however, is often the only way to establish
the diagnosis, and even benign tumours may recur, as shown
by one of our cases.
The vast majority of LFTP have a benign clinical course.
Long term survival with no recurrence is the rule in 80–88%
of the cases [1,8,10]. The macroscopic as well as the histo-
logic aspect of the tumour have prognostic implications. In
the series of 223 cases reported by England, two (1.4%) of
the 141 patients with a benign tumour had recurrence, but
there was no mortality related to the tumour in this group.
On the contrary, 55% of the histologically malignant
tumours had an aggressive behaviour. In our series, five
patients with a malignant LFTP had recurrence, which
was responsible for death in two. Of interest is our patient
who had subtotal resection followed by radiotherapy for
recurrence 15 months after total excision of two separate
histologically benign LFTPs. This patient is alive with no
evidence of disease 24 years after the first resection. We
could not find any data in the literature regarding the role
of radiotherapy in LFTP. Histological malignancy alone,
however, does not necessarily imply a poor outcome. The
macroscopic characteristics of the tumour are also impor-
tant. Local invasiveness, a broad based tumour, absence of a
pedicle, necrosis and haemorrhage within the tumour, and
poor delimitation all worsen the prognosis, as does incom-
plete surgical resection, which, taken alone, is the most
important prognostic factor. Recurrence is usually local.
Although not always possible, re-resection should be
attempted whenever possible. Three of our patients with
recurrence had a second resection, with a good outcome.
Diffuse recurrence within the chest and distant metastases
have been reported [1].
5. Conclusion
Over 80% of LFTP are clinically benign, and more than
50% are asymptomatic. The pre-operative diagnosis is dif-
ficult to establish. Transparietal needle biopsy has a low
diagnostic yield, and thoracotomy is very often necessary
for diagnosis. Treatment consists in complete resection.
Thoracoscopy may be sufficient for small lesions. Strict
histological and immunohistochemical criteria have been
established to diagnose LFTP. Histologically malignant
lesions, broad-based or locally invasive tumours, as well
as poorly delineated masses, bear a high risk of recurrence,
even after complete surgical resection. On the other hand,
local recurrence may occur even after removal of macro-
scopically and microscopically clearly benign tumours.
Long term follow-up therefore is mandatory in all cases.
The role of radiotherapy remains to be defined.
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